Robert Redner, MD

Hematologist Oncologist, Professor of Medicine

location_city UPMC Mario Lemieux Center for Blood Cancers

42 years treating Acute Myeloid Leukemia

Clinical Expertise

Dr. Redner's research interest has been the molecular biology of leukemic transformation and myeloid differentiation. A major focus of his laboratory has been the mechanism underlying differentiation arrest in myeloid leukemia, investigating acute promyelocytic leukemia (APL) as a model system. His group first cloned the NPM-RAR translocation that characterizes the t(5;17) variant of APL, and we have had an active program studying the mechanism by which NPM-RAR generates the leukemic phenotype